MYMYMY personal page - To The Moon

MYMYMY

No personal profile

14Follow

0Followers

0Topic

0Badge

2021-07-30

Wow

Is a Meltdown on the Way for Moderna Stock?

2021-07-30

Anyone bought this? Share your experience please

This Growth Stock Could Make You a Millionaire

2021-07-30

!!!!

Sorry, the original content has been removed

2021-07-29

Hope not

Is Netflix's Move Into Gaming a Sign Its Best Days Are Over?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4090287568866580","uuid":"4090287568866580","gmtCreate":1627184654276,"gmtModify":1627184654276,"name":"MYMYMY","pinyin":"mymymy","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":14,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":806296170,"gmtCreate":1627656372690,"gmtModify":1703494294478,"author":{"id":"4090287568866580","authorId":"4090287568866580","name":"MYMYMY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090287568866580","authorIdStr":"4090287568866580"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806296170","repostId":"2155373781","repostType":4,"repost":{"id":"2155373781","pubTimestamp":1627647922,"share":"https://ttm.financial/m/news/2155373781?lang=&edition=fundamental","pubTime":"2021-07-30 20:25","market":"us","language":"en","title":"Is a Meltdown on the Way for Moderna Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2155373781","media":"Motley Fool","summary":"There are certainly reasons to think the biotech stock is overpriced right now.","content":"<p>Move over, Murphy's law. Everything that could go right for&nbsp;<b>Moderna</b> (NASDAQ:MRNA) seems to be going right. The company was added to the <b>S&amp;P 500</b> index. Sales of its COVID-19 vaccine are booming, and its share price has more than tripled so far this year.</p>\n<p>However, all of this success could have some investors wondering just how long the momentum will last. And sometimes, when a good run ends, it isn't a pretty picture. Could a meltdown be on the way for Moderna stock?</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f6c071faeb9786d52d87adcab160eab7\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Lofty heights</h2>\n<p>There's no question that Moderna's valuation has reached lofty heights of late. The vaccine-maker's market cap is close to $130 billion, making Moderna <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest biotech stocks on the market.</p>\n<p>Let's put that market cap in perspective. Moderna has one product on the market, compared to a multitude of products for <b>Pfizer</b>. Moderna's projected sales this year are only a fraction of what Pfizer will likely make. The company's pipeline looks tiny versus Pfizer's, and yet Moderna is now valued at more than half of Pfizer's market cap.</p>\n<p>Consider <b>Regeneron</b>&nbsp;and <b>Vertex</b>, two of the most successful biotechs around. Regeneron has multiple blockbuster drugs on the market, and Vertex enjoys a monopoly in treating the underlying cause of cystic fibrosis. Moderna is currently worth more than Regeneron and Vertex <i>combined</i>.</p>\n<h2>Considerable uncertainty</h2>\n<p>Moderna's valuation probably wouldn't be very concerning if the company could count on the revenue that it will make in 2021 and 2022 continuing over the long run. However, there's considerable uncertainty as to whether or not that will be the case.</p>\n<p>No one knows for sure how long Moderna's COVID-19 vaccine will provide protection against infection. The longer the duration of immunity, the fewer vaccine doses that the company will sell.</p>\n<p>Perhaps emerging coronavirus variants could force the need for booster doses. For now, though, Moderna's vaccine appears to be holding up relatively well against variants, especially in preventing severe cases of COVID-19.</p>\n<p>Remember, too, that Moderna's vaccine currently requires two doses. Even if booster shots are needed going forward, it's probable that only single shots will be used.</p>\n<p>This lower volume will negatively impact Moderna's future revenue unless the company doubles its price per dose. If Moderna took that option, though, it could set the stage for rivals to capture more market share.</p>\n<h2>A meltdown in the making?</h2>\n<p>A sky-high valuation plus serious questions about the future could add up to a meltdown in the making for many stocks. Will that happen with Moderna? Maybe.</p>\n<p>I've been bullish about Moderna for a long time. However, even I don't think it's worth more than half the market cap of Pfizer and more than Regeneron and Vertex combined.</p>\n<p>Still, though, I don't predict a meltdown for Moderna stock. Yes, I fully expect the biotech's shares will fall from current levels. However, my take is that there'll be more of a gradual decline instead of a crash.</p>\n<p>There's a real possibility that the current worries about the delta variant fade away. As those concerns decrease, so could Moderna's share price. But that's more likely to happen over a period of months instead of on a super-quick basis.</p>\n<p>Even if Moderna stock falls, as I think it eventually will, my view of the company's long-term prospects remains upbeat. I look for Moderna to crank out more successful messenger RNA (mRNA) vaccines and therapies over the next decade and beyond.</p>\n<p>The company won't be able to avoid Murphy's law forever. However, I anticipate that more will go right for Moderna over the long run than will go wrong.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is a Meltdown on the Way for Moderna Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs a Meltdown on the Way for Moderna Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 20:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/30/is-a-meltdown-on-the-way-for-moderna-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Move over, Murphy's law. Everything that could go right for Moderna (NASDAQ:MRNA) seems to be going right. The company was added to the S&P 500 index. Sales of its COVID-19 vaccine are booming, and ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/30/is-a-meltdown-on-the-way-for-moderna-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/07/30/is-a-meltdown-on-the-way-for-moderna-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155373781","content_text":"Move over, Murphy's law. Everything that could go right for Moderna (NASDAQ:MRNA) seems to be going right. The company was added to the S&P 500 index. Sales of its COVID-19 vaccine are booming, and its share price has more than tripled so far this year.\nHowever, all of this success could have some investors wondering just how long the momentum will last. And sometimes, when a good run ends, it isn't a pretty picture. Could a meltdown be on the way for Moderna stock?\nImage source: Getty Images.\nLofty heights\nThere's no question that Moderna's valuation has reached lofty heights of late. The vaccine-maker's market cap is close to $130 billion, making Moderna one of the biggest biotech stocks on the market.\nLet's put that market cap in perspective. Moderna has one product on the market, compared to a multitude of products for Pfizer. Moderna's projected sales this year are only a fraction of what Pfizer will likely make. The company's pipeline looks tiny versus Pfizer's, and yet Moderna is now valued at more than half of Pfizer's market cap.\nConsider Regeneron and Vertex, two of the most successful biotechs around. Regeneron has multiple blockbuster drugs on the market, and Vertex enjoys a monopoly in treating the underlying cause of cystic fibrosis. Moderna is currently worth more than Regeneron and Vertex combined.\nConsiderable uncertainty\nModerna's valuation probably wouldn't be very concerning if the company could count on the revenue that it will make in 2021 and 2022 continuing over the long run. However, there's considerable uncertainty as to whether or not that will be the case.\nNo one knows for sure how long Moderna's COVID-19 vaccine will provide protection against infection. The longer the duration of immunity, the fewer vaccine doses that the company will sell.\nPerhaps emerging coronavirus variants could force the need for booster doses. For now, though, Moderna's vaccine appears to be holding up relatively well against variants, especially in preventing severe cases of COVID-19.\nRemember, too, that Moderna's vaccine currently requires two doses. Even if booster shots are needed going forward, it's probable that only single shots will be used.\nThis lower volume will negatively impact Moderna's future revenue unless the company doubles its price per dose. If Moderna took that option, though, it could set the stage for rivals to capture more market share.\nA meltdown in the making?\nA sky-high valuation plus serious questions about the future could add up to a meltdown in the making for many stocks. Will that happen with Moderna? Maybe.\nI've been bullish about Moderna for a long time. However, even I don't think it's worth more than half the market cap of Pfizer and more than Regeneron and Vertex combined.\nStill, though, I don't predict a meltdown for Moderna stock. Yes, I fully expect the biotech's shares will fall from current levels. However, my take is that there'll be more of a gradual decline instead of a crash.\nThere's a real possibility that the current worries about the delta variant fade away. As those concerns decrease, so could Moderna's share price. But that's more likely to happen over a period of months instead of on a super-quick basis.\nEven if Moderna stock falls, as I think it eventually will, my view of the company's long-term prospects remains upbeat. I look for Moderna to crank out more successful messenger RNA (mRNA) vaccines and therapies over the next decade and beyond.\nThe company won't be able to avoid Murphy's law forever. However, I anticipate that more will go right for Moderna over the long run than will go wrong.","news_type":1},"isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806291594,"gmtCreate":1627656294518,"gmtModify":1703494292003,"author":{"id":"4090287568866580","authorId":"4090287568866580","name":"MYMYMY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090287568866580","authorIdStr":"4090287568866580"},"themes":[],"htmlText":"Anyone bought this? Share your experience please&nbsp;","listText":"Anyone bought this? Share your experience please&nbsp;","text":"Anyone bought this? Share your experience please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806291594","repostId":"2155553961","repostType":4,"repost":{"id":"2155553961","pubTimestamp":1627651527,"share":"https://ttm.financial/m/news/2155553961?lang=&edition=fundamental","pubTime":"2021-07-30 21:25","market":"us","language":"en","title":"This Growth Stock Could Make You a Millionaire","url":"https://stock-news.laohu8.com/highlight/detail?id=2155553961","media":"Motley Fool","summary":"Zillow Group is disrupting the residential real estate industry.","content":"<p>Like many industries, residential real estate is undergoing a digital transformation. In addition to the ability to browse homes online, consumers want tools like 3D virtual tours, digital floor plans, and video walkthroughs with agents. And younger generations expect even more.</p>\n<p>According to a recent study from <b><a href=\"https://laohu8.com/S/Z\">Zillow</a> Group</b> (NASDAQ:Z) (NASDAQ:ZG), over <a href=\"https://laohu8.com/S/AONE.U\">one</a>-third of Gen Z and millennial consumers&nbsp;would be comfortable buying a home online. Collectively, these trends create an opportunity for disruption, and Zillow is leading the charge.</p>\n<p>Here's why this stock could make you a millionaire.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0c603c1ee1eb5e3b2e9bda0f6cf4e33f\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images</span></p>\n<h2>A big market opportunity</h2>\n<p>In 2006 Zillow launched the first version&nbsp;of its website. This ad-powered marketplace brought transparency to the real estate industry, allowing consumers to browse listings and view home value estimates&nbsp;in real time. But Zillow has since expanded on that digital-first foundation.</p>\n<p>Today, the company connects renters with landlords and homebuyers and sellers with agents, and it provides access to mortgage, title, and escrow services. This end-to-end approach streamlines transactions, removing the complexities created by third-party lenders and closing service providers.</p>\n<p>Zillow also buys homes directly through its Zillow Offers business, giving sellers the certainty of an all-cash offer and the convenience of never having to list their homes. In short, Zillow simplifies residential real estate, one of the largest markets in the U.S. In fact, management puts the company's market opportunity&nbsp;at over $300 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/849e4ca12a8d05ab97c2d842298cdb21\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Zillow Group</span></p>\n<h2><b>A strong competitive position</b></h2>\n<p>Zillow has become synonymous with real estate. Last year, 9.6 billion people visited the company's websites and mobile apps, making Zillow the most visited brand in the industry, according to Comscore. More importantly, because the company draws more viewers to its listings, Zillow can acquire customers at a lower cost than its rivals.</p>\n<p>Likewise, its foundational Internet, Media, and Technology (IMT) business -- which comprises ad revenue from real estate agents, rental properties, and home builders -- is profitable. In fact, Zillow generated more gross profit in 2020 than any other tech company in the real estate space. That extra cash flow means Zillow can outspend its rivals.</p>\n<p>Collectively, these advantages have translated into solid financial results.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q1 2018 (TTM)</p></th>\n   <th><p>Q1 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$1.0 billion</p></td>\n   <td width=\"156\"><p>$1.8 billion</p></td>\n   <td width=\"156\"><p>19%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Free cash flow</p></td>\n   <td width=\"156\"><p>$139.8 million</p></td>\n   <td width=\"156\"><p>$276.9 million</p></td>\n   <td width=\"156\"><p>26%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Source: Ycharts. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Zillow's financial performance is made all the more impressive by its recent transformation. With the launch of Zillow Offers in April 2018, the company started buying and selling homes directly. Of course, homes aren't cheap, and this business requires sizable upfront investments that erode gross profit.</p>\n<p>However, management is moving up the learning curve. Zillow sold 5,337 homes in 2020, up 24%&nbsp;from the prior year. More importantly, the company reported a 9% gross margin in its Homes business in Q1 2021, up from 5% in Q1 2020. Investors should look for Zillow to maintain that momentum.</p>\n<h2>A bright future</h2>\n<p>Since Q1 2001, the median price for houses sold in the U.S. has climbed from $169,800 to $374,900. Put another way, home prices tend to rise about 4% annually. To add to that, millennials represent the largest generation in the country, and as they age into their homebuying years Zillow believes the number of U.S. households will rise 5% by 2025.</p>\n<p>In other words, the residential real estate market should see rising prices and increased demand in the years ahead, meaning Zillow's market opportunity should only get bigger.</p>\n<p>More importantly, I believe the future of real estate is more streamlined and digital, and Zillow's business model plays into that trend. Yet the company's trailing-12-month revenue of $3.4 billion&nbsp;represents a fraction of its addressable market. That's why I think this stock could grow tenfold over the next decade.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Growth Stock Could Make You a Millionaire</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Growth Stock Could Make You a Millionaire\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 21:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/30/growth-stock-could-make-you-a-millionaire-zillow/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Like many industries, residential real estate is undergoing a digital transformation. In addition to the ability to browse homes online, consumers want tools like 3D virtual tours, digital floor plans...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/30/growth-stock-could-make-you-a-millionaire-zillow/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZG":"Zillow Class A","Z":"Zillow"},"source_url":"https://www.fool.com/investing/2021/07/30/growth-stock-could-make-you-a-millionaire-zillow/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155553961","content_text":"Like many industries, residential real estate is undergoing a digital transformation. In addition to the ability to browse homes online, consumers want tools like 3D virtual tours, digital floor plans, and video walkthroughs with agents. And younger generations expect even more.\nAccording to a recent study from Zillow Group (NASDAQ:Z) (NASDAQ:ZG), over one-third of Gen Z and millennial consumers would be comfortable buying a home online. Collectively, these trends create an opportunity for disruption, and Zillow is leading the charge.\nHere's why this stock could make you a millionaire.\nImage source: Getty Images\nA big market opportunity\nIn 2006 Zillow launched the first version of its website. This ad-powered marketplace brought transparency to the real estate industry, allowing consumers to browse listings and view home value estimates in real time. But Zillow has since expanded on that digital-first foundation.\nToday, the company connects renters with landlords and homebuyers and sellers with agents, and it provides access to mortgage, title, and escrow services. This end-to-end approach streamlines transactions, removing the complexities created by third-party lenders and closing service providers.\nZillow also buys homes directly through its Zillow Offers business, giving sellers the certainty of an all-cash offer and the convenience of never having to list their homes. In short, Zillow simplifies residential real estate, one of the largest markets in the U.S. In fact, management puts the company's market opportunity at over $300 billion.\nImage source: Zillow Group\nA strong competitive position\nZillow has become synonymous with real estate. Last year, 9.6 billion people visited the company's websites and mobile apps, making Zillow the most visited brand in the industry, according to Comscore. More importantly, because the company draws more viewers to its listings, Zillow can acquire customers at a lower cost than its rivals.\nLikewise, its foundational Internet, Media, and Technology (IMT) business -- which comprises ad revenue from real estate agents, rental properties, and home builders -- is profitable. In fact, Zillow generated more gross profit in 2020 than any other tech company in the real estate space. That extra cash flow means Zillow can outspend its rivals.\nCollectively, these advantages have translated into solid financial results.\n\n\n\nMetric\nQ1 2018 (TTM)\nQ1 2021 (TTM)\nCAGR\n\n\n\n\nRevenue\n$1.0 billion\n$1.8 billion\n19%\n\n\nFree cash flow\n$139.8 million\n$276.9 million\n26%\n\n\n\nSource: Ycharts. TTM = trailing-12-months. CAGR = compound annual growth rate.\nZillow's financial performance is made all the more impressive by its recent transformation. With the launch of Zillow Offers in April 2018, the company started buying and selling homes directly. Of course, homes aren't cheap, and this business requires sizable upfront investments that erode gross profit.\nHowever, management is moving up the learning curve. Zillow sold 5,337 homes in 2020, up 24% from the prior year. More importantly, the company reported a 9% gross margin in its Homes business in Q1 2021, up from 5% in Q1 2020. Investors should look for Zillow to maintain that momentum.\nA bright future\nSince Q1 2001, the median price for houses sold in the U.S. has climbed from $169,800 to $374,900. Put another way, home prices tend to rise about 4% annually. To add to that, millennials represent the largest generation in the country, and as they age into their homebuying years Zillow believes the number of U.S. households will rise 5% by 2025.\nIn other words, the residential real estate market should see rising prices and increased demand in the years ahead, meaning Zillow's market opportunity should only get bigger.\nMore importantly, I believe the future of real estate is more streamlined and digital, and Zillow's business model plays into that trend. Yet the company's trailing-12-month revenue of $3.4 billion represents a fraction of its addressable market. That's why I think this stock could grow tenfold over the next decade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808293973,"gmtCreate":1627583709992,"gmtModify":1703492840281,"author":{"id":"4090287568866580","authorId":"4090287568866580","name":"MYMYMY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090287568866580","authorIdStr":"4090287568866580"},"themes":[],"htmlText":"!!!!","listText":"!!!!","text":"!!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/808293973","repostId":"1131153172","repostType":4,"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801447577,"gmtCreate":1627531003199,"gmtModify":1703491807486,"author":{"id":"4090287568866580","authorId":"4090287568866580","name":"MYMYMY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090287568866580","authorIdStr":"4090287568866580"},"themes":[],"htmlText":"Hope not","listText":"Hope not","text":"Hope not","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/801447577","repostId":"2154927641","repostType":4,"repost":{"id":"2154927641","pubTimestamp":1627530360,"share":"https://ttm.financial/m/news/2154927641?lang=&edition=fundamental","pubTime":"2021-07-29 11:46","market":"us","language":"en","title":"Is Netflix's Move Into Gaming a Sign Its Best Days Are Over?","url":"https://stock-news.laohu8.com/highlight/detail?id=2154927641","media":"Motley Fool","summary":"The company is dipping its toes into a new entertainment market as subscriber growth shows signs of slowing.","content":"<p><b>Netflix</b> (NASDAQ:NFLX) gave investors a lot to chew on in its second-quarter earnings report. The company beat its own guidance for subscriber additions, but it disappointed with lower-than-expected guidance for the third quarter. Management is guiding for 3.5 million paid subscriber additions in the current period, falling short of the 5.6 million analyst consensus.&nbsp;To top things off, Netflix also confirmed its plans to expand into video games.</p>\n<p>The combination of weak guidance with the news of its entry into a new entertainment medium makes it seem the company is getting desperate for growth. But Netflix still has a long runway to expand, and this video game initiative makes sense for a few reasons.</p>\n<h2>Growth is slowing</h2>\n<p>There's no question that as Netflix becomes a larger business, its year-over-year subscriber growth will gradually slow. The company now serves over 209 million paid subscribers,. Before the pandemic, Netflix's year-over-year subscriber growth was gradually decelerating, falling from almost 26% at the end of 2018 to 20% the following year.</p>\n<p>Still, the long-term opportunity in streaming is massive. Despite a decade of growth, all streaming services still have less share of TV time than traditional linear TV. The latter has a 63% share of total U.S. TV time, according to <b>Nielsen</b>, while all streaming platforms have a 27% share. Netflix's share of TV time is even smaller at 7%.</p>\n<p>As the company notes in its earnings report, \"We are still very much in the early days of the transition from linear to on-demand consumption of entertainment.\" And if Netflix can hit its third-quarter subscriber guidance (3.5 million net additions), it will have added enough subscribers over the last 24 months to maintain its pre-pandemic growth rate.</p>\n<p>Some investors might still wonder about increasing competition and the impact it could have on Netflix's ability to add new subscribers, but management believes if it can offer more content, growth should continue like it has for two decades.</p>\n<p>And that brings us to gaming.</p>\n<h2>The reason for games</h2>\n<p>In that context, gaming doesn't appear to be any more of a response to competition or slowing growth than Netflix's move into original content in 2012. Netflix says it is early in its expansion into games, but they will be included at no extra cost to members and featured primarily on mobile devices. It's basically another content category like animation and unscripted TV.</p>\n<p>The company could emerge as a top developer on mobile platforms. It's going to focus on making games that don't require in-app purchases and ads, which run the risk of disrupting the gaming experience. In this way, Netflix could carve itself a unique position as a user-friendly platform that leads to increasing screen time among its members.</p>\n<p>It doesn't need to worry about charging for these games, because higher screen time and engagement should eventually pay off in the form of higher subscription revenue per membership. In the last quarter, Netflix saw its average revenue per membership increase 8%.&nbsp;This follows a 5% increase in the previous quarter.</p>\n<p>The entry into games also signals Netflix's improving profitability. It expects to reach free-cash-flow breakeven in 2021, and it no longer has a need to raise external financing to fund operations.</p>\n<p>With its operating margin expected to reach 20% this year, the company can afford to invest in new opportunities without shortchanging itself on spending for original movies and series.</p>\n<p>Looking at the big picture, this push into gaming could be the first step for Netflix to graduate from a pure-play streaming stock to a more broad-based entertainment company. Expanding its umbrella of opportunities should spell a wider competitive moat and more returns for investors.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Netflix's Move Into Gaming a Sign Its Best Days Are Over?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Netflix's Move Into Gaming a Sign Its Best Days Are Over?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-29 11:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/28/is-netflixs-gaming-move-a-sign-best-days-are-over/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Netflix (NASDAQ:NFLX) gave investors a lot to chew on in its second-quarter earnings report. The company beat its own guidance for subscriber additions, but it disappointed with lower-than-expected ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/28/is-netflixs-gaming-move-a-sign-best-days-are-over/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞"},"source_url":"https://www.fool.com/investing/2021/07/28/is-netflixs-gaming-move-a-sign-best-days-are-over/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2154927641","content_text":"Netflix (NASDAQ:NFLX) gave investors a lot to chew on in its second-quarter earnings report. The company beat its own guidance for subscriber additions, but it disappointed with lower-than-expected guidance for the third quarter. Management is guiding for 3.5 million paid subscriber additions in the current period, falling short of the 5.6 million analyst consensus. To top things off, Netflix also confirmed its plans to expand into video games.\nThe combination of weak guidance with the news of its entry into a new entertainment medium makes it seem the company is getting desperate for growth. But Netflix still has a long runway to expand, and this video game initiative makes sense for a few reasons.\nGrowth is slowing\nThere's no question that as Netflix becomes a larger business, its year-over-year subscriber growth will gradually slow. The company now serves over 209 million paid subscribers,. Before the pandemic, Netflix's year-over-year subscriber growth was gradually decelerating, falling from almost 26% at the end of 2018 to 20% the following year.\nStill, the long-term opportunity in streaming is massive. Despite a decade of growth, all streaming services still have less share of TV time than traditional linear TV. The latter has a 63% share of total U.S. TV time, according to Nielsen, while all streaming platforms have a 27% share. Netflix's share of TV time is even smaller at 7%.\nAs the company notes in its earnings report, \"We are still very much in the early days of the transition from linear to on-demand consumption of entertainment.\" And if Netflix can hit its third-quarter subscriber guidance (3.5 million net additions), it will have added enough subscribers over the last 24 months to maintain its pre-pandemic growth rate.\nSome investors might still wonder about increasing competition and the impact it could have on Netflix's ability to add new subscribers, but management believes if it can offer more content, growth should continue like it has for two decades.\nAnd that brings us to gaming.\nThe reason for games\nIn that context, gaming doesn't appear to be any more of a response to competition or slowing growth than Netflix's move into original content in 2012. Netflix says it is early in its expansion into games, but they will be included at no extra cost to members and featured primarily on mobile devices. It's basically another content category like animation and unscripted TV.\nThe company could emerge as a top developer on mobile platforms. It's going to focus on making games that don't require in-app purchases and ads, which run the risk of disrupting the gaming experience. In this way, Netflix could carve itself a unique position as a user-friendly platform that leads to increasing screen time among its members.\nIt doesn't need to worry about charging for these games, because higher screen time and engagement should eventually pay off in the form of higher subscription revenue per membership. In the last quarter, Netflix saw its average revenue per membership increase 8%. This follows a 5% increase in the previous quarter.\nThe entry into games also signals Netflix's improving profitability. It expects to reach free-cash-flow breakeven in 2021, and it no longer has a need to raise external financing to fund operations.\nWith its operating margin expected to reach 20% this year, the company can afford to invest in new opportunities without shortchanging itself on spending for original movies and series.\nLooking at the big picture, this push into gaming could be the first step for Netflix to graduate from a pure-play streaming stock to a more broad-based entertainment company. Expanding its umbrella of opportunities should spell a wider competitive moat and more returns for investors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":806291594,"gmtCreate":1627656294518,"gmtModify":1703494292003,"author":{"id":"4090287568866580","authorId":"4090287568866580","name":"MYMYMY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090287568866580","authorIdStr":"4090287568866580"},"themes":[],"htmlText":"Anyone bought this? Share your experience please&nbsp;","listText":"Anyone bought this? Share your experience please&nbsp;","text":"Anyone bought this? Share your experience please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806291594","repostId":"2155553961","repostType":4,"isVote":1,"tweetType":1,"viewCount":173,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806296170,"gmtCreate":1627656372690,"gmtModify":1703494294478,"author":{"id":"4090287568866580","authorId":"4090287568866580","name":"MYMYMY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090287568866580","authorIdStr":"4090287568866580"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/806296170","repostId":"2155373781","repostType":4,"repost":{"id":"2155373781","pubTimestamp":1627647922,"share":"https://ttm.financial/m/news/2155373781?lang=&edition=fundamental","pubTime":"2021-07-30 20:25","market":"us","language":"en","title":"Is a Meltdown on the Way for Moderna Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2155373781","media":"Motley Fool","summary":"There are certainly reasons to think the biotech stock is overpriced right now.","content":"<p>Move over, Murphy's law. Everything that could go right for&nbsp;<b>Moderna</b> (NASDAQ:MRNA) seems to be going right. The company was added to the <b>S&amp;P 500</b> index. Sales of its COVID-19 vaccine are booming, and its share price has more than tripled so far this year.</p>\n<p>However, all of this success could have some investors wondering just how long the momentum will last. And sometimes, when a good run ends, it isn't a pretty picture. Could a meltdown be on the way for Moderna stock?</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f6c071faeb9786d52d87adcab160eab7\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Lofty heights</h2>\n<p>There's no question that Moderna's valuation has reached lofty heights of late. The vaccine-maker's market cap is close to $130 billion, making Moderna <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest biotech stocks on the market.</p>\n<p>Let's put that market cap in perspective. Moderna has one product on the market, compared to a multitude of products for <b>Pfizer</b>. Moderna's projected sales this year are only a fraction of what Pfizer will likely make. The company's pipeline looks tiny versus Pfizer's, and yet Moderna is now valued at more than half of Pfizer's market cap.</p>\n<p>Consider <b>Regeneron</b>&nbsp;and <b>Vertex</b>, two of the most successful biotechs around. Regeneron has multiple blockbuster drugs on the market, and Vertex enjoys a monopoly in treating the underlying cause of cystic fibrosis. Moderna is currently worth more than Regeneron and Vertex <i>combined</i>.</p>\n<h2>Considerable uncertainty</h2>\n<p>Moderna's valuation probably wouldn't be very concerning if the company could count on the revenue that it will make in 2021 and 2022 continuing over the long run. However, there's considerable uncertainty as to whether or not that will be the case.</p>\n<p>No one knows for sure how long Moderna's COVID-19 vaccine will provide protection against infection. The longer the duration of immunity, the fewer vaccine doses that the company will sell.</p>\n<p>Perhaps emerging coronavirus variants could force the need for booster doses. For now, though, Moderna's vaccine appears to be holding up relatively well against variants, especially in preventing severe cases of COVID-19.</p>\n<p>Remember, too, that Moderna's vaccine currently requires two doses. Even if booster shots are needed going forward, it's probable that only single shots will be used.</p>\n<p>This lower volume will negatively impact Moderna's future revenue unless the company doubles its price per dose. If Moderna took that option, though, it could set the stage for rivals to capture more market share.</p>\n<h2>A meltdown in the making?</h2>\n<p>A sky-high valuation plus serious questions about the future could add up to a meltdown in the making for many stocks. Will that happen with Moderna? Maybe.</p>\n<p>I've been bullish about Moderna for a long time. However, even I don't think it's worth more than half the market cap of Pfizer and more than Regeneron and Vertex combined.</p>\n<p>Still, though, I don't predict a meltdown for Moderna stock. Yes, I fully expect the biotech's shares will fall from current levels. However, my take is that there'll be more of a gradual decline instead of a crash.</p>\n<p>There's a real possibility that the current worries about the delta variant fade away. As those concerns decrease, so could Moderna's share price. But that's more likely to happen over a period of months instead of on a super-quick basis.</p>\n<p>Even if Moderna stock falls, as I think it eventually will, my view of the company's long-term prospects remains upbeat. I look for Moderna to crank out more successful messenger RNA (mRNA) vaccines and therapies over the next decade and beyond.</p>\n<p>The company won't be able to avoid Murphy's law forever. However, I anticipate that more will go right for Moderna over the long run than will go wrong.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is a Meltdown on the Way for Moderna Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs a Meltdown on the Way for Moderna Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 20:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/30/is-a-meltdown-on-the-way-for-moderna-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Move over, Murphy's law. Everything that could go right for Moderna (NASDAQ:MRNA) seems to be going right. The company was added to the S&P 500 index. Sales of its COVID-19 vaccine are booming, and ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/30/is-a-meltdown-on-the-way-for-moderna-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/07/30/is-a-meltdown-on-the-way-for-moderna-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155373781","content_text":"Move over, Murphy's law. Everything that could go right for Moderna (NASDAQ:MRNA) seems to be going right. The company was added to the S&P 500 index. Sales of its COVID-19 vaccine are booming, and its share price has more than tripled so far this year.\nHowever, all of this success could have some investors wondering just how long the momentum will last. And sometimes, when a good run ends, it isn't a pretty picture. Could a meltdown be on the way for Moderna stock?\nImage source: Getty Images.\nLofty heights\nThere's no question that Moderna's valuation has reached lofty heights of late. The vaccine-maker's market cap is close to $130 billion, making Moderna one of the biggest biotech stocks on the market.\nLet's put that market cap in perspective. Moderna has one product on the market, compared to a multitude of products for Pfizer. Moderna's projected sales this year are only a fraction of what Pfizer will likely make. The company's pipeline looks tiny versus Pfizer's, and yet Moderna is now valued at more than half of Pfizer's market cap.\nConsider Regeneron and Vertex, two of the most successful biotechs around. Regeneron has multiple blockbuster drugs on the market, and Vertex enjoys a monopoly in treating the underlying cause of cystic fibrosis. Moderna is currently worth more than Regeneron and Vertex combined.\nConsiderable uncertainty\nModerna's valuation probably wouldn't be very concerning if the company could count on the revenue that it will make in 2021 and 2022 continuing over the long run. However, there's considerable uncertainty as to whether or not that will be the case.\nNo one knows for sure how long Moderna's COVID-19 vaccine will provide protection against infection. The longer the duration of immunity, the fewer vaccine doses that the company will sell.\nPerhaps emerging coronavirus variants could force the need for booster doses. For now, though, Moderna's vaccine appears to be holding up relatively well against variants, especially in preventing severe cases of COVID-19.\nRemember, too, that Moderna's vaccine currently requires two doses. Even if booster shots are needed going forward, it's probable that only single shots will be used.\nThis lower volume will negatively impact Moderna's future revenue unless the company doubles its price per dose. If Moderna took that option, though, it could set the stage for rivals to capture more market share.\nA meltdown in the making?\nA sky-high valuation plus serious questions about the future could add up to a meltdown in the making for many stocks. Will that happen with Moderna? Maybe.\nI've been bullish about Moderna for a long time. However, even I don't think it's worth more than half the market cap of Pfizer and more than Regeneron and Vertex combined.\nStill, though, I don't predict a meltdown for Moderna stock. Yes, I fully expect the biotech's shares will fall from current levels. However, my take is that there'll be more of a gradual decline instead of a crash.\nThere's a real possibility that the current worries about the delta variant fade away. As those concerns decrease, so could Moderna's share price. But that's more likely to happen over a period of months instead of on a super-quick basis.\nEven if Moderna stock falls, as I think it eventually will, my view of the company's long-term prospects remains upbeat. I look for Moderna to crank out more successful messenger RNA (mRNA) vaccines and therapies over the next decade and beyond.\nThe company won't be able to avoid Murphy's law forever. However, I anticipate that more will go right for Moderna over the long run than will go wrong.","news_type":1},"isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808293973,"gmtCreate":1627583709992,"gmtModify":1703492840281,"author":{"id":"4090287568866580","authorId":"4090287568866580","name":"MYMYMY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090287568866580","authorIdStr":"4090287568866580"},"themes":[],"htmlText":"!!!!","listText":"!!!!","text":"!!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/808293973","repostId":"1131153172","repostType":4,"repost":{"id":"1131153172","pubTimestamp":1627571715,"share":"https://ttm.financial/m/news/1131153172?lang=&edition=fundamental","pubTime":"2021-07-29 23:15","market":"us","language":"en","title":"Here’s how Zuckerberg thinks Facebook will profit by building a ‘metaverse’","url":"https://stock-news.laohu8.com/highlight/detail?id=1131153172","media":"CNBC","summary":"KEY POINTS\n\nFacebook CEO Mark Zuckerberg outlined some of his vision for a metaverse on the company’","content":"<div>\n<p>KEY POINTS\n\nFacebook CEO Mark Zuckerberg outlined some of his vision for a metaverse on the company’s earnings call this week.\nZuckerberg said it will take several years to build out the metaverse ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/29/facebook-metaverse-plans-to-make-money.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s how Zuckerberg thinks Facebook will profit by building a ‘metaverse’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s how Zuckerberg thinks Facebook will profit by building a ‘metaverse’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-29 23:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/07/29/facebook-metaverse-plans-to-make-money.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nFacebook CEO Mark Zuckerberg outlined some of his vision for a metaverse on the company’s earnings call this week.\nZuckerberg said it will take several years to build out the metaverse ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/29/facebook-metaverse-plans-to-make-money.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.cnbc.com/2021/07/29/facebook-metaverse-plans-to-make-money.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1131153172","content_text":"KEY POINTS\n\nFacebook CEO Mark Zuckerberg outlined some of his vision for a metaverse on the company’s earnings call this week.\nZuckerberg said it will take several years to build out the metaverse experience.\nIf Facebook is successful, it will make money from the sale of virtual goods in the metaverse, along with advertising and other virtual experiences.\n\nIt’s either the next evolution of the internet or the latest corporate buzzword to get investors excited over some nebulous innovation that may not even come to pass over the next decade.\nEither way, tech companies — primarily Facebook— are increasingly boosting the concept of the “metaverse,” the classic sci-fi term for a virtual world you can live, work and play inside. If you’ve seen the movie “Ready Player One,” you have a pretty good idea of what the metaverse is: Strap on a set of computerized glasses, and you’re transported into a digital universe where anything is possible.\nFacebook CEO Mark Zuckerberg is the most bullish on the concept,announcing his plans earlier this month to pivot Facebook from a social media company to a metaverse company in the coming years.\nIt’s less clear how tech companies can profit off the metaverse concept.\nZuckerberg, his executive team and Wall Street analysts spent a lot of time on the company’s earnings call on Wednesday discussing the metaverse, how much it’ll cost Facebook to build and how Facebook plans to profit from it.\nIn fact, “metaverse” was mentioned 20 times on the hour-long call. There were 28 mentions of advertising, Facebook’s core business that brought in more than $28 billion in revenue for the quarter.\nHere’s the business case Zuckerberg and his team made for Facebook’s investment in the metaverse:\nFacebook will sell the hardware, but that’s not where the real money comes from.Zuckerberg said on the earnings call that Facebook’s goal is to sell its headsets as cheaply as possible and focus on making money through commerce and advertising within the metaverse itself.\n“Our business model isn’t going to primarily be around trying to sell devices at a large premium or anything like that because our mission is around serving as many people as possible,” Zuckerberg said on the earnings call. “So we want to make everything that we do as affordable as possible, so as many people as possible can get into it and then compounds the size of the digital economy inside it.”\nFacebook already runs Oculus, the virtual reality division of the company. Today, Oculus’ VR headsets are relatively limited in what they can do. But Facebook’s hope is to improve the technology so the headsets look more like a pair of Warby Parker glasses instead of a clunky helmet. According to Zuckerberg, the metaverse will only work if the hardware can provide the user a true sense of presence in the digital world.\nAdvertising will still play a role, but Facebook will focus on the sale of virtual goods.Zuckerberg said advertising in the metaverse will be “an important part” of Facebook’s strategy to profit off the metaverse, but he sounded more bullish on commerce in the digital world.\nMany consider some of today’s video games like Microsoft’s Minecraft, Roblox and Fortnite early versions of what a metaverse could be. Those free games make money by selling virtual goods to players. Zuckerberg hinted on the earnings call Facebook would copy that strategy to make money in its own metaverse, taking a slice of every transaction.\n“I think digital goods and creators are just going to be huge... in terms of people expressing themselves through their avatars, through digital clothing, through digital goods, the apps that they have, that they bring with them from place to place,” Zuckerberg said. “A lot of the metaverse experience is going to be around being able to teleport from one experience to another. So being able to basically have your digital goods and your inventory and bring them from place to place, that’s going to be a big investment that people make.”\nFacebook is spending billions per year on the metaverse.The company wouldn’t provide a specific figure, but didn’t shoot down one analyst’s estimation that the company is spending about $5 billion per year on metaverse-related development.\nA reality check: It’s going to take years for Zuckerberg’s plans to play out, if they even happen at all.Tech companies love futuristic concepts that aren’t fully baked yet, like artificial intelligence. The definitions of these terms tend to get blurry and move away from the original concept. (Real artificial intelligence does not exist yet, for example, no matter how many Big Tech executives pretend it does.)\nThere’s a real risk the metaverse concept will fall into that same trap. As more and more companies, especially those like Facebook and Microsoft, talk up their metaverse strategies in the near term, keep in mind we’re still several years (or more) away from it becoming a reality. The technology still hasn’t caught up to the promise, and it won’t any time soon.","news_type":1},"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801447577,"gmtCreate":1627531003199,"gmtModify":1703491807486,"author":{"id":"4090287568866580","authorId":"4090287568866580","name":"MYMYMY","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4090287568866580","authorIdStr":"4090287568866580"},"themes":[],"htmlText":"Hope not","listText":"Hope not","text":"Hope not","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/801447577","repostId":"2154927641","repostType":4,"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}